Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

New Strong Buy Stocks for July 12th

Published 07/11/2021, 11:07 PM
Updated 07/09/2023, 06:31 AM

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

360 DigiTech, Inc. QFIN: This owner and operator of a digital consumer finance platform under the 360 Jietiao brand in China has seen the Zacks Consensus Estimate for its current year earnings increasing 8.1% over the last 60 days.

360 DigiTech, Inc. Sponsored ADR Price and Consensus

FedEx Corporation (NYSE:FDX) FDX: This provider of transportation, e-commerce, and business services, has seen the Zacks Consensus Estimate for its current year earnings increasing 6.4% over the last 60 days.

FedEx Corporation Price and Consensus

GreenSky, Inc. GSKY: This company that offers proprietary technology infrastructure platform to support the full transaction lifecycle, including credit application, underwriting and real-time allocation, has seen the Zacks Consensus Estimate for its current year earnings increasing 30.8% over the last 60 days.

GreenSky, Inc. Price and Consensus

Jabil Inc. JBL: This provider of electronic manufacturing services and solutions has seen the Zacks Consensus Estimate for its current year earnings increasing 9.7% over the last 60 days.

Jabil, Inc. Price and Consensus

MasterCraft Boat Holdings (NASDAQ:MCFT), Inc. MCFT: This designer, manufacturer and marketer of recreational powerboats has seen the Zacks Consensus Estimate for its current year earnings increasing 18.6% over the last 60 days.

MASTERCRAFT BOAT HOLDINGS, INC. Price and Consensus

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.


Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

FedEx Corporation (FDX): Free Stock Analysis Report

Jabil, Inc. (JBL): Free Stock Analysis Report

MASTERCRAFT BOAT HOLDINGS, INC. (MCFT): Free Stock Analysis Report

GreenSky, Inc. (GSKY): Free Stock Analysis Report

360 DigiTech, Inc. Sponsored ADR (QFIN): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.